Stock Updates

Today’s Top Gainers in the Market Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) from Healthcare

Today’s top gainers include the company Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) which is in the industry Biotechnology, gaining 2.07% today. In the last week its performance is -3.68%, and 3.33% for the past quarter. Currently, Alexion Pharmaceuticals, Inc., ALXN has a target price of 164.11, so today’s gain of 2.07% is a significant step towards its target price. The GAP today is therefore 0.04%.

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN), has a market cap of 27459.87, and is based in USA. Insider ownership is at 0.50%, and institutional ownership is 98.30%.

At the current price of 122.54, it has a dividend yield of *TBA, and its target price is 164.11. This is with a profit margin of 3.20%, and total debt/equity of 0.4. Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) has a P/E of 310.23, as well as a forward P/E of 20.98.

With a current EPS of 0.4, and a forecasted EPS growth for next year at 25.04%,Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) has had a EPS growth for the past five years at 5.10%. For the next five years EPS growth is projected to be 18.28%.

Performance for the year is -22.35%. Since its IPO date on 2/28/1996, the total performance to date is -35.76%.

Volume today for Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN), is 1881000, while its average volume is 1558.57. Whilst the total gain today was 2.07%, it did have a day high of -11.46%.

Volatility for this week has been at 3.20%, and 3.14% for the month. The 52-week low for Alexion Pharmaceuticals, Inc., ALXN has been 10.84%, while the 52-week-high has reached -36.66%.

Looking at its return of investments, which is 1.60%, and its return on assets is 0.70%. Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) has an operating margin of 21.70%. With a sales growth of 18.40% quarter over quarter. Bearing in mind that Alexion Pharmaceuticals, Inc., ALXN is in the sector Healthcare, its long-term debt/equity is 0.39, and has a current ratio of 3.6 and 3.1 for quick ratio.

So what is the value of Alexion Pharmaceuticals, Inc.? Well its PEG is 16.97, and the P/S is 9.73, along with a P/B of 3.35. Meanwhile it has a p/cash of 23.27.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Tony Dabbs

Leave a Comment